Page 146 - ASHG 2012 Annual Meeting Program Guide

POSTER SESSIONS
135
POSTER SESSIONS
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
619
T Genetic and clinical determinants of warfarin
dose: A RE-LY genomics substudy.
N. Eriksson, L.
Wallentin, L. Berglund, T. Axelsson, S. Connolly, M.
Ezekowitz, J. Oldgren, P. Guillaume, P. Reilly, A. Siegbahn,
A.-C. Syvänen, C. Wadelius, S. Yusuf, M. Wadelius.
620
T The Kaiser Permanente/UCSF Genetic
Epidemiology Research Study on Adult Health and
Aging: A genome-wide association study of quetiapine-
induced weight gain derived from electronic medical
records and outpatient pharmacy data.
N. Gonzaludo,
S. Sciortino, L. Walter, N. Risch, P. Y. Kwok, C. Schaefer.
621
T Genome-wide association analysis of pain
reduction in rheumatoid arthritis patients treated with
anti-TNF medication.
M. Umicevic Mirkov, H. Scheffer, S.
Krintel, S. H. Vermeulen, J. Johansen, W. Kievit, M. A. F.
van de Laar, P. C. L. van Riel, B. Franke, M. Hetland, M. J.
H. Coenen.
622
T A genome-wide association analysis of
corticosteroid response in asthmatics.
Q. Duan, B. E.
Himes, B. Schuemann, K. G. Tantisira, S. T. Weiss.
623
T microRNA-based approach expands on genome-
wide association study and identifies SNPs important
for response to glucocorticoids in asthma patients.
H. Im, E. R. Gamazon, D. Lenkala, K. Wu, G. Clemmer, S.
T. Weiss, N. J. Cox, K. Tantisira, R. S. Huang.
624
T SLC9A9 variant as a novel biomarker of response
to interferon beta: Results from a pharmacogenetic
study on Italian, U.S. and French multiple sclerosis
patients.
F. Martinelli Boneschi, F. Esposito, E. Lim, P.
Brambilla, M. Sorosina, M. Romeo, M. Rodegher, N.
Bohossian, N. A. Patsopoulos, B. Kenan, V. Martinelli, D.
Brassat, G. Comi, P. De Jager.
625
T Polygenic heritability estimates of asthma and
treatment-related phenotypes.
M. J. McGeachie, E. A.
Stahl, B. E. Himes, S. A. Pendergrass, M. D. Ritchie, R. M.
Plenge, K. G. Tantisira.
626
T Web-based phenotyping yields replication of
genetic associations with sensitivity to warfarin.
J. L.
Mountain, A. K. Kiefer, M. Mullins, T. K. Acquaye, C.
B. Marsh, J. A. Johnson, H. L. McLeod, J. Y. Tung, N.
Eriksson, K. E. Barnholt.
627
T Follow-up study of genetic risk factors for
carbamazepine-induced cutaneous adverse drug
reactions in Japanese population.
T. Ozeki, T. Mushiroda,
A. Takahashi, M. Kubo, Y. Shirakata, Z. Ikezawa, M. Iijima,
T. Shiohara, K. Hashimoto, Y. Nakamura.
628
T Re-examination of the CATIE pharmacogenetics
whole-genome dataset using a run of significiant
findings approach, focus on tardive dyskinesia.
C. Zai,
V. Gonçalves, A. Tiwari, G. Oh, V. de Luca, D. Mueller, J.
Knight, J. Kennedy.
629
T A Bayesian approach to genome-wide genetic
association studies with survival time as outcome.
L. Chien, I. Chang, C. Hsiung.
608
T Identification of novel polymorphisms associated
with efficiency of metformin treatment in type 2
diabetes patients.
J. Klovins, L. Tarasova, L. Zarina, V.
Pirags, OPTIMED Consortium.
609
T Cholesteryl ester transfer protein polymorphisms,
statin use, and their impact on cholesterol levels and
cardiovascular events.
M. Leusink, N. C. Onland-Moret,
F. W. Asselbergs, B. Ding, S. Kotti, N. R. van Zuydam,
A. C. Papp, N. Danchin, L. Donnelly, A. D. Morris, D. I.
Chasman, P. A. F. M. Doevendans, O. H. Klungel, P. M.
Ridker, W. H. van Gilst, T. Simon, F. Nyberg, C. N. A.
Palmer, W. Sadee, P. van der Harst, C. Verstuyft, P. I. W. de
Bakker, A. de Boer, A.-H. Maitland-van der Zee.
610
T Association study of inflammation-related
genes and depressive disorders and antidepressant
response.
M.-W. Lin, Y.-T. Chang, I.-H. Lin, Y.-M. Bai.
611
T Are
CYP2C9
and
VKORC1
polymorphisms
associated with increased bleeding or thrombosis risk
among Blacks receiving warfarin anticoagulation?
F.
Mili, T. A. Deans, W. C. Hooper, P. Weinstein, C. Lally, H.
Austin, N. Wenger.
612
T Twelve candidate genes and antidepressant
response in obsessive-compulsive disorder.
G. Zai, E.
Brandl, J. Deluce, J. L. Kennedy, M. A. Richter.
613
T A genome-wide integrative study of microRNAs
in human liver.
W. Liu, F. Innocenti, E. Gamazon, S.
Mirkov, J. Ramirez, S. Huang, N. Cox, M. Ratain.
614
T Protein quantitative trait loci identify novel
proteins predictive for chemotherapeutic induced
phenotypes.
A. L. Stark, R. J. Hause, Jr., L. K. Gorsic,
N. N. Antao, S. S. Wong, D. F. Gill, S. H. Chung, S. M.
Delaney, C. D. Brown, K. P. White, R. B. Jones, M. E.
Dolan.
615
T Functional genetic variation in
RHOA
is
associated with the cholesterol-lowering effects of
statin treatment.
E. Theusch, D. Naidoo, F. Bauzon, K.
Stevens, L. Mangravite, Y. L. Kuang, R. M. Krauss, M. W.
Medina.
616
T The modulation of CYP3A4 expression by the
efflux pump ABCB1 in HepG2 cells.
W. Shou, B. Wang,
Z. Wang, J. Shi, W. Huang.
617
T Genetic determinants of dabigatran plasma levels
and their relation to bleeding.
G. Pare, N. Eriksson,
T. Lehr, S. Connolly, J. Eikelboom, M. D. Ezekowitz, T.
Axelsson, S. Haertter, J. Oldgren, P. Reilly, A. Siegbahn,
A.-C. Syvänen, C. Wadelius, M. Wadelius, H. Zimdahl-
Gelling, S. Yusuf, L. Wallentin.
618
T Genome-wide study of resistant hypertension
using existing genomic data and electronic medical
records.
L. Dumitrescu, M. D. Ritchie, J. C. Denny, S. J.
Bielinski, P. Peissig, J. A. Pacheco, M. G. Hayes, G. P.
Jarvik, R. Li, I. J. Kullo, C. G. Chute, R. L. Chisholm, E. B.
Larson, C. A. McCarty, D. M. Roden, M. de Andrade, D. C.
Crawford on behalf of eMERGE Network.